Substantial reduction of basal cell carcinoma tumor size with itraconazole following treatment failure with intralesional 5-fluorouracil

被引：0
|
作者：
Patil, Nitin Krishna [1 ]
Bubna, Aditya Kumar [1 ,2 ]
机构：
[1] Katihar Med Coll, Dept Dermatol, Katihar, Bihar, India
[2] Katihar Med Coll, Dept Dermatol, Katihar 854106, Bihar, India
来源：
JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY | 2023年 / 20卷 / 01期
关键词：
HEDGEHOG PATHWAY;
D O I：
10.4103/jewd.jewd_31_22
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：60 / 62
页数：3
相关论文
共 50 条
  • [21] Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma
    Nazarali, Samina
    Sajic, Dusan
    JOURNAL OF DRUGS IN DERMATOLOGY, 2023, 22 (12) : 1166 - 1171
  • [22] Intralesional 5-Fluorouracil for the Nonsurgical Management of Low-Risk, Invasive Squamous Cell Carcinoma
    Dando, Emily E.
    Lim, Geoffrey F. S.
    Lim, Scott J. M.
    Kim, ChangHyun
    Pugliano-Mauro, Melissa
    DERMATOLOGIC SURGERY, 2020, 46 (01) : 126 - 130
  • [23] Therapeutic options for the treatment of colorectal cancer following 5-fluorouracil failure
    Henderson, CA
    SEMINARS IN ONCOLOGY, 1998, 25 (05) : 29 - 38
  • [24] Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil
    Midena, E
    Angeli, CD
    Valenti, M
    de Belvis, V
    Boccato, P
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (03) : 268 - 272
  • [25] Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU)
    Roozeboom, Marieke H.
    van Kleef, Lotte
    Arits, Aimee H. M. M.
    Mosterd, Klara
    Winnepenninckx, Veronique J. L.
    van Marion, Arienne M. W.
    Nelemans, Patty J.
    Kelleners-Smeets, Nicole W. J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) : 93 - 98
  • [26] A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier
    Romagosa, R
    Saap, L
    Givens, M
    Salvarrey, A
    He, JL
    Hsia, SL
    Taylor, JR
    DERMATOLOGIC SURGERY, 2000, 26 (04) : 338 - 340
  • [27] Treatment of renal cell carcinoma with 5-fluorouracil and alfa-interferon
    Gebrosky, NP
    Koukol, S
    Nseyo, UO
    Carpenter, C
    Lamm, DL
    UROLOGY, 1997, 50 (06) : 863 - 867
  • [28] 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: Efficacy, tolerability, cosmetic outcome, and patient satisfaction
    Gross, Kenneth
    Kircik, Leon
    Kricorian, Greg
    DERMATOLOGIC SURGERY, 2007, 33 (04) : 433 - 440
  • [29] TREATMENT OF A BASAL-CELL EPITHELIOMA BY A 1-PERCENT 5-FLUOROURACIL SOLUTION
    JADASSOH.W
    PAILLARD, R
    HUNZIKER, N
    LOZERON, H
    MAGGIORA, A
    ORUSCO, M
    DERMATOLOGICA, 1969, 139 (05): : 337 - &
  • [30] A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier - Commentary
    Arpey, CJ
    DERMATOLOGIC SURGERY, 2000, 26 (04) : 340 - 340
12345